Nicotinamide Riboside (NR)

NR · Niagen · Tru Niagen

Ancillary peptide Published Clinical Data

Overview

NAD+ precursor supplement. May also inhibit CD38 (NAD-degrading enzyme), offering dual benefit. 250–500mg daily. 2026 clinical trial showed equivalent NAD+ elevation to NMN. Some evidence NR partially converts to NMN in the gut — the distinction may be academic. Preferred by some for cost/availability.

Used in Regimens

Nicotinamide Riboside (NR) is not currently part of any catalog regimen.

Related Tools

Track Nicotinamide Riboside (NR) with Doseline

Reminders, medication level charts, injection site rotation, and protocol tracking — all free, all private.

Join the waitlist

Doseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.

Doseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.